Mast Therapeutics, Inc. (MSTX)

8.37
0.12 1.39
AMEX
Prev Close 8.49
Open 8.39
Day Low/High 8.13 / 8.43
52 Wk Low/High 4.60 / 42.35
Volume 2.81K
Exchange AMEX
Shares Outstanding 254.75B
Div & Yield N.A. (N.A)

Latest News

Mast Therapeutics Announces Possible Adjournment Of Special Stockholders Meeting To Solicit Additional Votes For Merger With Savara

Over 95% of Votes Cast to Date are in Favor of the Merger, but More Votes Are Necessary to Achieve Quorum and Approval of All Required Proposals

Mast Reminds Stockholders To Vote For The Proposed Merger With Savara

-- Of the Votes Received to Date, More than 90% Are Voting in Favor of the Merger

Mast Therapeutics And Savara Announce Approval To List Common Stock On The Nasdaq Capital Market

Special Meeting of Mast Therapeutics Stockholders to Be Held on April 21, 2017

Mast Therapeutics Sets Date For Special Meeting Of Stockholders To Vote On Proposed Merger With Savara

Special Meeting To Be Held on April 21, 2017

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

How to Trade These Most Active Stocks -- LifeLock, Tyson Foods and More

How to Trade These Most Active Stocks -- LifeLock, Tyson Foods and More

Here's a technical look on how to trade some of the most active stocks on the market right now.

5 Big-Volume Stocks to Add to Your Buy List -- Plus 2 to Avoid

5 Big-Volume Stocks to Add to Your Buy List -- Plus 2 to Avoid

Here's a technical look at how to trade some of the most active stocks on the market right now.

MSTX April 2017 Options Begin Trading

MSTX April 2017 Options Begin Trading

Investors in Mast Therapeutics, Inc saw new options become available today, for the April 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Mast Sickle Cell Drug Seeks to Defy Long Odds Like Leicester City

Mast Sickle Cell Drug Seeks to Defy Long Odds Like Leicester City

Very few people expect Mast's compound to become the first, new drug for sickle cell disease in almost 20 years. That's why Mast carries a miniscule $60 million market value.

3 Stocks Under $10 to Trade for Big Breakouts

3 Stocks Under $10 to Trade for Big Breakouts

These stocks trading for less than $10 a share are within range of triggering breakout trades.

Biotech Stock Mailbag: MannKind, Mast Therapeutics, Bluebird

Biotech Stock Mailbag: MannKind, Mast Therapeutics, Bluebird

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Two Small-Cap Biotechnology Gems

For speculative investors.

4 Biotech Stocks Under $10 to Watch for Breakout Trades

4 Biotech Stocks Under $10 to Watch for Breakout Trades

These biotech stocks trading for under $10 are starting to push higher into breakout territory.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks are within range of triggering breakout trades.

Interesting MSTX Put And Call Options For January 2015

Interesting MSTX Put And Call Options For January 2015

Investors in Mast Therapeutics, Inc saw new options become available today, for the January 2015 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 243 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

A Small-Cap Biotech Stock With Promise: MSTX

A Small-Cap Biotech Stock With Promise: MSTX

This small-cap biotech stock could be setting up for a great buying opportunity here following the massive selloff in the space.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to trade higher from current levels.

Interesting MSTX Call Options For October 18th

Interesting MSTX Call Options For October 18th

Investors in Mast Therapeutics, Inc saw new options begin trading this week, for the October 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Interesting MSTX Call Options For March 22nd

Interesting MSTX Call Options For March 22nd

Investors in Mast Therapeutics, Inc saw new options become available this week, for the March 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MSTX options chain for the new March 22nd contracts and identified the following call contract of particular interest.

5 Stocks Under $10 on the Verge of Breakouts

5 Stocks Under $10 on the Verge of Breakouts

These under-$10 stocks are within range of triggering breakout trades.

2 Biotech Stocks Under $10 to Watch

2 Biotech Stocks Under $10 to Watch

Keep these biotech stocks on your radar.